10 results match your criteria: "National Institute of Pharmaceutical Education and Research-Raebareli (Transit Campus)[Affiliation]"

N-Arylsulfonylated C-Homoaporphines as a New Class of Antiplatelet and Antimicrobial Agents.

ACS Med Chem Lett

January 2025

Laboratory of Organic and Medicinal Chemistry, Department of Chemistry, Malaviya National Institute of Technology, Jawaharlal Nehru Marg, Jaipur 302017, India.

A series of novel N-arylsulfonylated C-homoaporphine alkaloids were synthesized under microwave irradiation and evaluated for their antiplatelet and antimicrobial activities. Among the series, compounds , , , , , , , , and demonstrated highly potent (∼3-fold) platelet aggregation inhibitory activity than acetylsalicylic acid (IC = 21.34 μg/mL).

View Article and Find Full Text PDF

Therapeutic role of NLRP3 inflammasome inhibitors against Alzheimer's disease.

Bioorg Chem

December 2024

Laboratory of Bioactive Heterocycles and Catalysis (BHC Lab), Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research-Raebareli (Transit Campus), Bijnor-Sisendi Road, Near CRPF Base Camp, Sarojini Nagar, Lucknow 226002, India. Electronic address:

The NLRP3 inflammasome is a multiprotein complex that plays a vital role in regulating inflammatory signaling and the innate immune system. Activation of NLRP3 by accumulation of Aβ leads to its oligomerization and the activation of caspase-1, resulting in the secretion of pro-cytokines such as IL-18 and IL-1β. These pro-cytokines can contribute to cognitive impairment and neurodegeneration.

View Article and Find Full Text PDF

Pyrazolo[1,5-]pyrimidine as a Prominent Framework for Tropomyosin Receptor Kinase (Trk) Inhibitors-Synthetic Strategies and SAR Insights.

Molecules

July 2024

Laboratory of Bioactive Heterocycles and Catalysis (BHC Lab), Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research-Raebareli (Transit Campus), Bijnor-Sisendi Road, Near CRPF Base Camp, Sarojini Nagar, Lucknow 226002, India.

Article Synopsis
  • * First-generation TRK inhibitors like Larotrectinib and Entrectinib were approved in 2018-2019 but faced resistance issues, leading to the FDA approval of second-generation inhibitor Repotrectinib in November 2023, and Selitrectinib provides further solutions.
  • * The article emphasizes the development and structure-activity relationships of pyrazolo[1,5-
View Article and Find Full Text PDF

Targeting cancer using scaffold-hopping approaches: illuminating SAR to improve drug design.

Drug Discov Today

September 2024

Laboratory of Bioactive Heterocycles and Catalysis (BHC lab), Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research-Raebareli (Transit Campus), Bijnor-Sisendi Road, Near CRPF Base Camp, Sarojini Nagar, Lucknow 226002, India. Electronic address:

Scaffold hopping is a design approach involving alterations to the core structure of an already bioactive scaffold to generate novel molecules to discover bioactive hit compounds with innovative core structures. Scaffold hopping enhances selectivity and potency while maintaining physicochemical, pharmacodynamic (PD), and pharmacokinetic (PK) properties, including toxicity parameters. Numerous molecules have been designed based on a scaffold-hopping strategy that showed potent inhibition activity against multiple targets for the diverse types of malignancy.

View Article and Find Full Text PDF

Malaria is a life-threatening disease that affects tropical and subtropical regions worldwide. Various drugs were used to treat malaria, including artemisinin and derivatives, antibiotics (tetracycline, doxycycline), quinolines (chloroquine, amodiaquine), and folate antagonists (sulfadoxine and pyrimethamine). Since the malarial parasites developed drug resistance, there is a need to develop new chemical entities with high efficacy and low toxicity.

View Article and Find Full Text PDF
Article Synopsis
  • * The structures of these compounds were confirmed through various analytical techniques, including NMR, HRMS, and single crystal X-ray crystallography, helping to determine their stereochemical arrangements.
  • * In vitro tests showed that some of these compounds exhibited significant anticancer activity against human lung and liver cancer cell lines, outperforming standard treatments like artemisinin and chloroquine, although none were more effective than artesunic acid.
View Article and Find Full Text PDF

A copper-promoted regiodivergent, AcOH-switchable, distal and proximal direct cyanation of -aryl-(1/2)-indazoles via aerobic oxidative C(sp)-H bond activation has been developed. The inclusion or exclusion of AcOH as an additive is the foremost cause for the positional switch in the C-CN bond formation method that results in (C-2')-cyanated 2-aryl-2-indazoles , (C-2')-cyanated 1-aryl-1-indazoles [distal], or C-3 cyanated 2-aryl-2-indazoles [proximal] products in good to excellent yields and showed various functional group tolerance. The cyanide (CN) ion surrogate was generated via the unification of dimethylformamide and ammonium iodide (NHI).

View Article and Find Full Text PDF

An unprecedented TMEDA-catalyzed, regioselective, decarboethoxy direct C-N coupling protocol towards the synthesis of dibenzopyrrocolines 17 a-i and 5,6-dihydroindolo[2,1-a]isoquinoline 15 a-f/18 a-c alkaloids via the identification of N,N,N',N'-tetramethylethylenediamine (TMEDA) as a homogeneous catalyst is reported. The transition-metal-free, TMEDA-catalytic novel protocol is operationally simple and showed a wide range of functional group tolerance and substrate compatibility. The gram-scale application and synthesis of naturally occurring Cryptaustoline (dibenzopyrrocoline) alkaloid, further highlights the importance and versatile nature of the developed protocol.

View Article and Find Full Text PDF

A highly efficient oxidant-switched palladium-catalyzed regioselective C-H/C-H cross-dehydrogenative coupling (CDC) for direct mono/bis-aroylation of substituted 1-phenyl-1-indazoles with various substituted aldehydes via C-H bond activation has been developed. In this study, Pd-catalyzed chelation-assisted mono- or bis-aroylation of substituted 1-phenyl1-indazoles depends on the type of oxidant being used for the CDC reaction. While mono--aroylation of substituted 1-phenyl-1-indazole was obtained using dicumylperoxide (DCP) as the oxidant, the bis--aroylation product has been afforded by the use of -butyl hydroperoxide (TBHP).

View Article and Find Full Text PDF

Novel halogenated arylvinyl-1,2,4 trioxanes as potent antiplasmodial as well as anticancer agents: Synthesis, bioevaluation, structure-activity relationship and in-silico studies.

Eur J Med Chem

November 2021

Laboratory of Organic and Medicinal Chemistry, Department of Chemistry, Malaviya National Institute of Technology, Jawaharlal Nehru Marg, Jaipur, 302017, India; Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research-Raebareli (Transit Campus), Bijnor-Sisendi Road, Near CRPF Base Camp, Sarojini Nagar, Lucknow, U.P, 226 002, India. Electronic address:

Herein, we have synthesized a series of lipophilic, halogenated-arylvinyl-1,2,4-trioxanes 8a-g (28 compounds) and assessed for their in vitro anti-plasmodial activity in Plasmodium falciparum culture using SYBRgreen-I fluorescence assay against chloroquine-resistant Pf INDO and artemisinin-resistant Pf Cam 3.1 (MRA-1240) strains. Alongside, the cell cytotoxic potential of 8a-g has also been determined against the HEK293 cell line in vitro.

View Article and Find Full Text PDF